Poor Outcomes of Patients With Relapsed/Refractory DLBCL Requiring More Than One Salvage Therapy Followed by Autologous HCT

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2017.12.234
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

R-Ivac Salvage Therapy in Relapsed and Refractory DLBCL

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Very Early FDG Pet/Ct Scan May Predict Outcomes in Relapsed or Refractory DLBCL Patients Treated With Salvage Therapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Toxicity-Reduced, Myeloablative Allograft Followed by Lenalidomide Maintenance as Salvage Therapy for Refractory/Relapsed Myeloma Patients

Bone Marrow Transplantation
TransplantationHematology
2012English

Highly Favorable Outcomes With Rt Followed by Asct in Low/Low-Intermediate Secondary Age Adjusted Ipi Rel/Ref DLBCL Patients Refractory to Salvage Chemotherapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Brentuximab Vedotin Salvage Followed by Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in High Risk Relapsed Refractory Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Outcomes of Autologous Stem Cell Transplantation (ASCT) in Patients With Relapsed/Refractory HIV-associated Lymphoma

Bone Marrow Transplantation
TransplantationHematology
2016English

Clinical Outcomes From Venetoclax Based Therapy in Patients With Relapsed/Refractory B-Cell Lymphomas

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients With Relapsed/Refractory Acute Myeloid Leukemia

Advances in Hematology
Hematology
2017English

A Phase I Clinical Study of Autologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple Myeloma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy